These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7111962)

  • 1. Interactions of rifampin and trimethoprim in vitro.
    Alvarez S; DeMaria A; Kulkarni R; Klein JO; McCabe WR
    Rev Infect Dis; 1982; 4(2):390-401. PubMed ID: 7111962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.
    Goldstein BP; Ripamonti IF; Bolzoni G; Carniti G; Arioli V
    Antimicrob Agents Chemother; 1979 Dec; 16(6):736-42. PubMed ID: 533255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
    Vilchèze C; Jacobs WR
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides.
    O'Brien TF; Acar JF; Altmann G; Blackburn BO; Chao L; Courtieu AL; Evans DA; Guzman M; Holmes M; Jacobs MR; Kent RL; Norton RA; Koornhof HJ; Medeiros AA; Pasculle AW; Surgalla MJ; Williams JD
    Rev Infect Dis; 1982; 4(2):351-7. PubMed ID: 7111960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.
    Kuipers JS
    Chemotherapy; 1979; 25(2):77-82. PubMed ID: 446188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimicrobial activities of trimethoprim and sulfonamides.
    Burman LG
    Scand J Infect Dis; 1986; 18(1):3-13. PubMed ID: 3515508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents.
    Mengelers MJ; van Klingeren B; van Miert AS
    Am J Vet Res; 1990 Nov; 51(11):1860-4. PubMed ID: 2240813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of trimethoprim at a subinhibitory concentration on the appearance of mutants resistant to rifampicin].
    Joly B; Sirot D; Sirot J; Reynaud A; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):497-500. PubMed ID: 6348656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of equine Salmonella strains to trimethoprim and sulfonamide alone or in combination.
    van Duijkeren E; van Klingeren B; Vulto AG; Sloet van Oldruitenborgh-Oosterbaan MM; Breukink HJ; van Miert AS
    Am J Vet Res; 1994 Oct; 55(10):1386-90. PubMed ID: 7998695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
    Varaldo PE; Debbia E; Schito GC
    Antimicrob Agents Chemother; 1983 Mar; 23(3):402-6. PubMed ID: 6221692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim and rifampicin: in vitro activities separately and in combination.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1975 Dec; 1(4):417-27. PubMed ID: 1206027
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin.
    Farrell W; Wilks M; Drasar FA
    J Antimicrob Chemother; 1977 Sep; 3(5):459-62. PubMed ID: 903326
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of sulfamethoxazole-trimethoprim synergistic action against members of the family Enterobacteriaceae with a two-plate agar dilution breakpoint MIC system.
    Ward PB; Carson M; Dodd JS; Pavillard ER
    J Clin Microbiol; 1984 Jun; 19(6):899-901. PubMed ID: 6381529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of anaerobes to co-trimoxazole.
    Wüst J
    Infection; 1980; 8 Suppl 2():S187-9. PubMed ID: 7450860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of trimethoprim and quinolones against gram-negative fish pathogens.
    Inglis V; Cafini M; Yoshida T
    J Appl Bacteriol; 1995 Aug; 79(2):135-40. PubMed ID: 7592108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.
    Bourgault AM; Forward KR; Ronald AR; Harding GK; Thomson M; Grey G
    Antimicrob Agents Chemother; 1981 Apr; 19(4):513-8. PubMed ID: 7247374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.